J&J knew of Risperdal's risks to boys, Lawyer says; GSK plans overhaul of consumer health image;

 @FiercePharma: J&J Hid Risks Risperdal Makes Boys' Breasts Grow: Lawyer--Bloomberg. Report | Follow @FiercePharma

> Johnson & Johnson ($JNJ) knew its antispychotic drug Risperdal could cause boys to grow breasts, but hid those risks, a plaintiff's lawyer said in a Texas court. Report

> GlaxoSmithKline ($GSK) plans to reinvent its consumer healthcare division as a high-profile consumer brand, rather than a division of a Big Pharma company. Report

> Bayer plans to set up its new centralized finance and accounting center in Gdansk, which will start operations later this year and reach full strength in 2014. Report

> The European Generic Medicines Association is protesting new pharmacovigilance fees, saying they put a disproportionate burden on makers of copycat drugs. Report

> Cancer Research UK expects the death rate from cancer in the U.K. to drop by 17% between 2010 and 2030 as diagnosis and treatment improve. Report

Medical Device News

 @FierceMedDev: Abbott Labs is launching its dissolvable coronary stent in Europe, Asia and Latin America. Release | Follow @FierceMedDev

 @MarkHFierce: Bad breath bacteria could be a pancreatic cancer clue. More | Follow @MarkHFierce

 @DamianFierce: Frost & Sullivan says devicemakers must adjust to new pricing pressures to stay afloat. More | Follow @DamianFierce

> Analysts: Devicemakers need to adapt to new economic reality. Article

> Apnex Medical snags $10M for apnea device. News

Biotech News

 @FierceBiotech: In case you missed it last week, check out our 2012 Fierce 15 report: Report | BPA 2012 Slideshow | Follow @FierceBiotech

 @JohnCFierce: One of the two nucs Vertex licensed from Alios ($60M/$1.5B) turned out to be a dud. The other one is headed for PhII. Vertex release | Follow @JohnCFierce

 @RyanMFierce: My interview with Daphne Zohar on how Appeering distills smart banter in biotech from the Twitter hose. Story | Follow @RyanMFierce

> New CEO at GenVec slashes jobs but shelters Novartis partnership. News

> Vertex dumps one hep C dud, races ahead with second all-oral hope. Article

> Is CRO giant Quintiles planning a multibillion-dollar IPO? More

> Sanofi to shed 900 workers with fate of R&D complex undecided. Story

Biotech Research News

> Roche, AstraZeneca lung cancer Rx beat Alzheimer's in fruit flies and mice. Article

> Constellation gains $7.5M to advance preclinical blood cancer drug. More

> Roswell Park researchers spot versatile cancer treatment. Story

> Natural killer cells may be key to lung cancer susceptibility. Item

And Finally... Health officials are scouting for cases of an emerging, SARS-like virus that has killed one person in Saudi Arabia and hospitalized another in the U.K. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.